HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.

AbstractOBJECTIVE:
To study the biodistribution of purified CD133(+) cells after intracoronary injection in patients with stable chronic postinfarction heart failure.
PATIENTS AND METHODS:
Patients with longstanding myocardial infarction (>12 months prior to inclusion) and with an accessible left coronary artery were eligible. CD133(+) cells were mobilized with granulocyte colony-stimulating factor and purified with a CliniMACS device. Cells were labeled with (111)Indium and injected through a balloon catheter in a coronary artery feeding the necrotic or viable infarct-related region of the left ventricle during a standard coronary catheterization procedure. The total body biodistribution of (111)Indium was studied with a dual-head gamma camera in combination with (99m)Technetium-sestaMIBI cardiac distribution analysis.
RESULTS:
The number of CD133(+) cells injected ranged between 5 and 10 x 10(6) cells (low dose, three patients) or between 18.5 and 50 x 10(6) cells (high dose, five patients). In the five patients receiving the higher cell doses, a clear residual radioactivity was observed at the level of the chronic injury at 2, 12, and up to 36 hours after injection. A detailed analysis in two patients showed 6.9% to 8.0% (after 2 hours) and 2.3% to 3.2% (after 12 hours) residual radioactivity at the heart. No adverse events were observed during the procedure and up to 3 months follow-up.
CONCLUSIONS:
We demonstrate that CD133(+) progenitor cells are capable of homing to the postinfarction remodeling myocardium after intracoronary injections in patients with chronic postinfarction heart failure.
AuthorsRik Schots, Gilles De Keulenaer, Danny Schoors, Vicky Caveliers, Martine Dujardin, Stefan Verheye, Guy Van Camp, Philippe R Franken, Jan Roland, Ivan Van Riet, Hendrik Everaert
JournalExperimental hematology (Exp Hematol) Vol. 35 Issue 12 Pg. 1884-90 (Dec 2007) ISSN: 0301-472X [Print] Netherlands
PMID17923244 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AC133 Antigen
  • Antigens, CD
  • Glycoproteins
  • PROM1 protein, human
  • Peptides
Topics
  • AC133 Antigen
  • Aged
  • Antigens, CD (immunology)
  • Chronic Disease
  • Female
  • Glycoproteins (immunology)
  • Heart Failure (pathology)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (immunology, pathology)
  • Myocardium (pathology)
  • Peptides (immunology)
  • Stem Cells (cytology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: